InSilixa

Sunnyvale, United States Founded: 2012 • Age: 14 yrs
Develops innovative point-of-care diagnostics using semiconductor-based CMOS biochip technology.

About InSilixa

InSilixa is a company based in Sunnyvale (United States) founded in 2012 by Arjang Hassibi. It operates as a B2B. InSilixa has raised $13 million across 2 funding rounds from investors including HHS, PointGuard Ventures and Morningside. The company has 40 employees. InSilixa operates in a competitive market with competitors including Cepheid, Prenetics, Karius, Day Zero Diagnostics and OpGen, among others.

  • Headquarter Sunnyvale, United States
  • Employees 40
  • Founders Arjang Hassibi
  • Sectors
    Healthcare
  • Website insilixa.com
  • Legal Name Insilixa, Inc.
Key Metrics
  • Total Equity Funding
    $13M (USD)

    in 2 rounds

  • Latest Funding Round
    $13M (USD), Series A

    Oct 2014

  • Investors
    HHS

    & 2 more

  • Employee Count
    40

Funding Insights of InSilixa

InSilixa has successfully raised a total of $13M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $13 million completed in October 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $13M
  • Total Rounds 2
  • Last Round Series A β€” $13M
  • First Round $1.79M

    (Sep 2013)

  • Investors Count 3

All 2 funding rounds of InSilixa with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2014$13MSeries A–PointGuard Ventures, Morningside
–
Sep 2013$1.79MGrant––
Valuation history

3 investors in total: 3 institutional.

Investors in InSilixa

InSilixa has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, PointGuard Ventures and Morningside.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage technology investments are made by PointGuard Ventures.
–pointguardventures.comLos Altos, United States
Multiple sectors are invested in by Morningside, a VC fund.
–morningside.comNewton, United States
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for InSilixa

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of InSilixa

15 people are tracked at InSilixa (4 in leadership, 8 in board & advisors, 3 in team); the tracked headcount is 40.

NameRoleGroup
Arjang Hassibi
Founder, CEOLeadership
Nader Gamini
COOLeadership
Krish Panu
Managing Director, PointGuard VenturesLeadership
Robert Kuimelis, PhD
VP ChemistryLeadership
Paul Auerbach
AdvisorBoard & advisors
Christopher Mcleod
Independent Investor, Director & AdvisorBoard & advisors
Thomas H. Lee
AdvisorBoard & advisors
Nick Roelofs
Independent Board MemberBoard & advisors
Gary Schoolnik
AdvisorBoard & advisors
Rich Meyer
Independent AdvisorBoard & advisors
Rich Redelfs
AdvisorBoard & advisors
Babak Hassibi
AdvisorBoard & advisors
Robert Rose
Sr. Staff Software EngineerTeam
Pallavi Raju
ScientistTeam
Ruma Sinha
ScientistTeam
Premium access

Complete people profiles for InSilixa

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of InSilixa

3 dated milestones of InSilixa across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded InSilixa is founded.
  2. Funding First funding round of $1.8M.
  3. Funding Latest funding round, Series A, of $13.0M.

Competitors of InSilixa

InSilixa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Prenetics, Karius, Day Zero Diagnostics and OpGen, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cepheid.com1996Sunnyvale, United States$19.1M1,299
Developer of molecular diagnostic testing solutions
prenetics.com2009Hong Kong, China$67.65M–
Health risks are identified through online genetic and diagnostic testing.
kariusdx.com2014Redwood, United States$315M139
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
dayzerodiagnostics.com2016Boston, United States$48.6M48
Genome sequencing diagnostics for infectious diseases are developed.
opgen.com2002Rockville, United States$77.51M100
Developer of diagnostics and bioinformatics platforms for providers
clearlabs.com2014Menlo Park, United States$171.09M55
Food safety technologies are provided for pathogen identification.
seluxdx.com2014Cambridge, United States$161.01M–
Developer of alternatives to traditional ELISA assays
springbankpharm.com2002Milford, United States$36.7M84
Viral infection treatments are developed using nucleic acid hybrid chemistry.
qvella.com2009Toronto, Canada$39.7M–
Develops innovative platforms for accurate and rapid bacteria diagnosis in healthcare.
Premium access

Detailed competitors of InSilixa

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of InSilixa

The website of InSilixa (insilixa.com) receives about 680.7K visits a month.

  • Monthly visits
    680.7K

    ▼ 6.7% vs previous month

Similar websites

Websites whose visitors overlap most with InSilixa. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
falconebiz.com
100%
959.8K#63,970View details
tofler.in
97%
556K#105,509View details
zaubacorp.com
96%
4.9M#12,689View details
tracxn.com
92%
2.9M#16,597View details
indiafilings.com
90%
2.1M#29,959View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for InSilixa

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Insilixa

InSilixa secures USD13m funding from PointGuard.
Thefreelibrary β€’ 7 years ago
Premium access

Complete news archive for InSilixa

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to InSilixa

10 companies that operate in the same segment as InSilixa (Traditional Diagnostics & Medical Devices), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Materials management solutions are provided for healthcare organizations.
1892Chicago, Illinois, United StatesUSD 29.13 MUSD 20.63 B53,000
3D-printed orthopedic products are manufactured for medical applications.
1941Kalamazoo, Michigan, United States–––
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United States–USD 5.1 B13,500
Heart pumps are developed for blood circulation and oxygenation support.
1981Danvers, Massachusetts, United States–USD 1.03 B1,157
Medical device management services are provided to healthcare facilities.
1999Exeter, New Hampshire, United StatesUSD 275.93 MUSD 68.67 M353
Medical surgical consumables including sutures and anti-microbial gloves are manufactured.
1992Bengaluru, Karnataka, IndiaUSD 102.36 MUSD 7.14 K39
Manufacturer of medical equipments
1967Bengaluru, Karnataka, IndiaUSD 58.9 MUSD 98.65 M578
BD is recognized for providing innovative medical technology solutions.
1897Franklin Lakes, New Jersey, United States–USD 21.84 B74,000
Dental lasers and scanning devices are developed for clinical use.
1987Foothill Ranch, California, United States–USD 49.16 M–
Manufacturer and distributor of aprons, surgical gowns, uniforms, and other medical products
1966Mundelein, Illinois, United States–USD 28.45 B1,305
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about InSilixa

InSilixa was founded in 2012 and raised its 1st funding round 1 year after it was founded.

InSilixa is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.

Arjang Hassibi is the current CEO of InSilixa. They have also founded this company.

InSilixa is a funded company, having raised a total of $13M across 2 funding rounds to date. The company's 1st funding round was a Grant of $1.79M, raised on Sep 2013.

InSilixa has 40 employees.

InSilixa, founded in 2012 in Sunnyvale, United States, focuses on providing healthcare solutions, developing medical devices, offering diagnostic solutions, and point-of-care. Develops innovative point-of-care diagnostics using semiconductor-based CMOS biochip technology. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

InSilixa's top competitors include Cepheid, Prenetics and Clear Labs.

InSilixa has 3 investors. Key investors include HHS, PointGuard Ventures, and Morningside.

InSilixa operates through Insilixa, Inc..

The website of InSilixa receives about 681 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available